Table 4.
Adjusted odds ratio (95% confidence interval) of the multivariate regression analyses of post-COVID concentration loss at T2 and T3 follow-up periods.
| T2 (13.2 months) | T3 (18.3 months) | |
|---|---|---|
| Age | 1.012 (0.986, 1.039) | 0.998 (0.976, 1.020) |
| Female sex | 1.763 (0.814, 3.820) | 1.340 (0.619, 2.903) |
| Weight | 1.008 (0.986, 1.032) | 1.004 (0.979, 1.030) |
| Medical co-morbidities | ||
| Hypertension | 1.202 (0.568, 2.542) | 0.642 (0.628, 1.428) |
| Diabetes | 1.641 (0.663, 4.062) | 0.450 (0.124, 1.635) |
| Cardiovascular diseases | 1.808 (0.731, 4.471) | 0.764 (0.233, 2.511) |
| Asthma | 1.172 (0.372, 3.693) | 0.520 (0.134, 2.007) |
| Obesity | 1.017 (0.465, 2.223) | 2.100 (0.468, 9.431) |
| Chronic obstructive pulmonary disease | 1.808 (0.443, 7.383) | 1.284 (0.236, 3.987) |
| Rheumatological diseases | 1.263 (0.519, 3.073) | 1.017 (0.104, 6.933) |
| Symptoms at hospital admission | ||
| Dyspnea | 1.149 (0.538, 2.455) | 0.774 (0.345, 1.602) |
| Cough | 0.589 (0.269, 1.292) | 0.476 (0.210, 1.080) |
| Myalgias | 1.038 (0.508, 2.124) | 0.789 (0.386, 1.611) |
| Headache | 0.688 (0.263, 1.802) | 1.402 (0.636, 3.095) |
| Diarrhea | 0.818 (0.303, 2.206) | 0.908 (0.346, 2.381) |
| Anosmia | 1.447 (0.322, 6.504) | 1.304 (0.387, 4.395) |
| Ageusia | 0.265 (0.050, 1.400) | 1.352 (0.267, 5.846) |
| Throat pain | 0.414 (0.077, 2.231) | 0.678 (0.172, 2.675) |
| Vomiting | 1.947 (0.373, 7.150) | 1.813 (0.492, 5.686) |
| Dizziness | 1.190 (0.325, 4.352) | 0.850 (0.200, 3.618) |
| Days at the hospital | 0.985 (0.950, 1.020) | 0.988 (0.957, 1.020) |
| Intensive care unit (ICU) admission | 0.559 (0.179, 1.748) | 1.343 (0.475, 3.798) |
| Concentration loss at T1 (8.4 months) | 19.467 (9.390, 40.357)# | 5.686 (3.154, 10.252)# |
#p < 0.001 and *p < 0.05.